Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments

키워드

참고문헌 (79)

1. Lin E, "Precision psychiatry applications with pharmacogenomics : artificial intelligence and machine learning approaches", Int J Mol Sci, 21, pp.969~ (2020)
2. Klein ME, "Clinical implementation of pharmacogenomics for personalized precision medicine : barriers and solutions", J Pharm Sci, 106, pp.2368~2379 (2017)
3. Torres EB, "Toward precision psychiatry : statistical platform for the personalized characterization of natural behaviors", Front Neurol, 7, pp.8~ (2016)
4. Amare AT, "Pharmacogenomics in the treatment of mood disorders : strategies and opportunities for personalized psychiatry", EPMA J, 8, pp.211~227 (2017)
5. Lin E, "Genome-wide microarray analysis of gene expression profiling in major depression and antidepressant therapy", Prog Neuropsychopharmacol Biol Psychiatry, 64, pp.334~340 (2016)
6. Lin E, "Genome-wide association studies in pharmacogenomics of antidepressants", Pharmacogenomics, 16, pp.555~566 (2015)
7. Lin E, "Multi-omics and machine learning applications in precision medicine", Curr Pharmacogen Personal Med, 15, pp.97~104 (2017)
8. Bzdok D, "Machine learning for precision psychiatry : opportunities and challenges", Biol Psychiatry Cogn Neurosci Neuroimaging, 3, pp.223~230 (2018)
9. Lin E, "Machine learning and systems genomics approaches for multi-omics data", Biomark Res, 5, pp.2~ (2017)
10. Athreya AP, "Integration of machine learning and pharmacogenomic biomarkers for predicting response to antidepressant treatment:can computational intelligence be used to augment clinical assessments?", Pharmacogenomics, 20, pp.983~988 (2019)
11. Litjens G, "A survey on deep learning in medical image analysis", Med Image Anal, 42, pp.60~88 (2017)
12. Ching T, "Opportunities and obstacles for deep learning in biology and medicine", J R Soc Interface, 15, pp.20170387~ (2018)
13. Dana D, "Deep learning in drug discovery and medicine; scratching the surface", Molecules, 23, pp.2384~ (2018)
14. Grapov D, "Rise of deep learning for genomic, proteomic, and metabolomic data integration in precision medicine", OMICS, 22, pp.630~636 (2018)
15. Zhang S, "Learning for personalized medicine : a comprehensive review from a deep learning perspective", IEEE Rev Biomed Eng, 12, pp.194~208 (2019)
16. LeCun Y, "Deep learning", Nature, 521, pp.436~444 (2015)
17. Hinton G, "Deep learning-a technology with the potential to transform health care", JAMA, 320, pp.1101~1102 (2018)
18. Hulshoff Pol H, "Neural networks in psychiatry", Eur Neuropsychopharmacol, 23, pp.1~6 (2013)
19. Ekins S, "The next era : deep learning in pharmaceutical research", Pharm Res, 33, pp.2594~2603 (2016)
20. Mamoshina P, "Applications of deep learning in biomedicine", Mol Pharm, 13, pp.1445~1454 (2016)
21. Falcone M, "Neuroimaging in psychiatric pharmacogenetics research : the promise and pitfalls", Neuropsychopharmacology, 38, pp.2327~2337 (2013)
22. Mufford MS, "Neuroimaging genomics in psychiatry-a translational approach", Genome Med, 9, pp.102~ (2017)
23. Davatzikos C, "Machine learning in neuroimaging : progress and challenges", Neuroimage, 197, pp.652~656 (2019)
24. Godlewska BR, "Neuroimaging as a tool for individualized treatment choice in depression : the past, the present and the future", Curr Behav Neurosci Rep, 7, pp.32~39 (2020)
25. Patel MJ, "Studying depression using imaging and machine learning methods", Neuroimage Clin, 10, pp.115~123 (2015)
26. Iniesta R, "Machine learning, statistical learning and the future of biological research in psychiatry", Psychol Med, 46, pp.2455~2465 (2016)
27. Lane HY, "Assessing gene-gene interactions in pharmacogenomics", Mol Diagn Ther, 16, pp.15~27 (2012)
28. Lin E, "Pattern-recognition tech-niques with haplotype analysis in pharmacogenomics", Pharmacogenomics, 8, pp.75~83 (2007)
29. Dwyer DB, "Machine learning approaches for clinical psychology and psychiatry", Annu Rev Clin Psychol, 14, pp.91~118 (2018)
30. Perlman K, "A systematic meta-review of predictors of antidepressant treatment outcome in major depressive disorder", J Affect Disord, 243, pp.503~515 (2019)
31. Huang LC, "A comparison of classification methods for predicting Chronic Fatigue Syndrome based on genetic data", J Transl Med, 7, pp.81~ (2009)
32. Maciukiewicz M, "GWAS-based machine learning approach to predict duloxetine response in major depressive disorder", J Psychiatr Res, 99, pp.62~68 (2018)
33. Tibshirani R, "The lasso method for variable selection in the Cox model", Stat Med, 16, pp.385~395 (1997)
34. Vapnik V, "The nature of statistical learning theory" (2013), Springer Science & Business Media
35. Lin E, "A support vector machine approach to assess drug efficacy of interferon-alpha and ribavirin combination therapy", Mol Diagn Ther, 12, pp.219~223 (2008)
36. Breiman L, "Random forests", Mach Learn, 45, pp.5~32 (2001)
37. Kautzky A, "The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression", Eur Neuropsychopharmacol, 25, pp.441~453 (2015)
38. Athreya AP, "Pharmacogenomics-driven prediction of antidepressant treatment outcomes : a machine-learning approach with multi-trial replication", Clin Pharmacol Ther, 106, pp.855~865 (2019)
39. Galar M, "A review on ensembles for the class imbalance problem : bagging-, boosting-, and hybrid-based approaches", IEEE Trans Syst Man Cybern Part C, 42, pp.463~484 (2011)
40. Yang P, "A review of ensemble methods in bioinformatics", Curr Bioinform, 5, pp.296~308 (2010)
41. Lin E, "An ensemble approach to predict schizophrenia using protein data in the N-methyl-D-aspartate receptor(NMDAR)and tryptophan catabolic pathways", Front Bioeng Biotechnol, 8, pp.569~ (2020)
42. Lin E, "Prediction of antidepressant treatment response and remission using an ensemble machine learning framework", Pharmaceuticals(Basel), 13, pp.305~ (2020)
43. Kohavi R, "Wrappers for feature subset selection", Artif Intell, 97, pp.273~324 (1997)
44. Rumelhart DE, "Parallel distributed processing: explorations in the microstructure of cognition. Vol. 1: foundations" (1996), MIT Press
45. Lin E, "A deep learning approach for predicting antidepressant response in major depression using clinical and genetic biomarkers", Front Psychiatry, 9, pp.290~ (2018)
46. Fonseka TM, "Neuroimaging biomarkers as predictors of treatment outcome in Major Depressive Disorder", J Affect Disord, 233, pp.21~35 (2018)
47. Kang SG, "Neuroimaging biomarkers for predicting treatment response and recurrence of major depressive disorder", Int J Mol Sci, 21, pp.2148~ (2020)
48. Janssen RJ, "Making individual prognoses in psychiatry using neuroimaging and machine learning", Biol Psychiatry Cogn Neurosci Neuroimaging, 3, pp.798~808 (2018)
49. Patel MJ, "Machine learning approaches for integrating clinical and imaging features in late-life depression classification and response prediction", Int J Geriatr Psychiatry, 30, pp.1056~1067 (2015)
50. Hariri AR, "Imaging genetics : perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing", Biol Psychiatry, 59, pp.888~897 (2006)
51. Rabl U, "Imaging genetics : implications for research on variable antidepressant drug response", Expert Rev Clin Pharmacol, 3, pp.471~489 (2010)
52. Thompson PM, "The ENIGMA Consortium : large-scale collaborative analyses of neuroimaging and genetic data", Brain Imaging Behav, 8, pp.153~182 (2014)
53. Lam RW, "Discovering biomarkers for antidepressant response : protocol from the Canadian biomarker integration network in depression(CAN-BIND)and clinical characteristics of the first patient cohort", BMC Psychiatry, 16, pp.105~ (2016)
54. Gottesman II, "The endophenotype concept in psychiatry : etymology and strategic intentions", Am J Psychiatry, 160, pp.636~645 (2003)
55. Meyer-Lindenberg A, "Intermediate phenotypes and genetic mechanisms of psychiatric disorders", Nat Rev Neurosci, 7, pp.818~827 (2006)
56. Viviani R, "Use of magnetic resonance imaging in pharmacogenomics", Br J Clin Pharmacol, 77, pp.684~694 (2014)
57. Buch AM, "Dissecting diagnostic heterogeneity in depression by integrating neuroimaging and genetics", Neuropsychopharmacology, 46, pp.156~175 (2021)
58. Carter CS, "Enhancing the informativeness and replicability of imaging genomics studies", Biol Psychiatry, 82, pp.157~164 (2017)
59. Pereira LP, "Imaging genetics paradigms in depression research : systematic review and meta-analysis", Prog Neuropsychopharmacol Biol Psychiatry, 86, pp.102~113 (2018)
60. Chang B, "ARPNet:antidepressant response prediction network for major depressive disorder", Genes(Basel), 10, pp.907~ (2019)
61. Pei C, "Ensemble learning for early-response prediction of antidepressant treatment in major depressive disorder", J Magn Reson Imaging, 52, pp.161~171 (2020)
62. Rutledge RB, "Machine learning and big data in psychiatry : toward clinical applications", Curr Opin Neurobiol, 55, pp.152~159 (2019)
63. Lin E, "Relevant applications of generative adversarial networks in drug design and discovery : molecular de novo design, dimensionality reduction, and de novo peptide and protein design", Molecules, 25, pp.3250~ (2020)
64. Kalinin AA, "Deep learning in pharmacogenomics : from gene regulation to patient stratification", Pharmacogenomics, 19, pp.629~650 (2018)
65. Jiao Y, "Performance measures in evaluating machine learning based bioinformatics predictors for classifications", Quant Biol, 4, pp.320~330 (2016)
66. Wong TT, "Performance evaluation of classification algorithms by k-fold and leave-one-out cross validation", Pattern Recognit, 48, pp.2839~2846 (2015)
67. Zou J, "A primer on deep learning in genomics", Nat Genet, 51, pp.12~18 (2019)
68. Russell LE, "Variant discovery using next-generation sequencing and its future role in pharmacogenetics", Pharmacogenomics, 21, pp.471~486 (2020)
69. Azodi CB, "Benchmarking parametric and machine learning models for genomic prediction of complex traits", G3(Bethesda), 9, pp.3691~3702 (2019)
70. Azodi CB, "Opening the black box : interpretable machine learning for geneticists", Trends Genet, 36, pp.442~455 (2020)
71. Eraslan G, "Deep learning : new computational modelling techniques for genomics", Nat Rev Genet, 20, pp.389~403 (2019)
72. Kalamara A, "How to find the right drug for each patient? Advances and challenges in pharmacogenomics", Curr Opin Syst Biol, 10, pp.53~62 (2018)
73. Najafabadi MM, "Deep learning applications and challenges in big data analytics", J Big Data, 2, pp.1~ (2015)
74. Goodfellow I, "Generative adversarial nets" (2014), University of Montreal
75. Lin E, "A deep adversarial variational autoencoder model for dimensionality reduction in single-cell RNA sequencing analysis", BMC Bioinformatics, 21, pp.64~ (2020)
76. Lin E, "Combination of G72 genetic variation and G72 protein level to detect schizophrenia : machine learning approaches", Front Psychiatry, 9, pp.566~ (2018)
77. Angermueller C, "Deep learning for computational biology", Mol Syst Biol, 12, pp.878~ (2016)
78. Lin E, "Soft computing for biological systems", pp.13~22 (2018), Springer
79. Litjens G, "Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosis", Sci Rep, 6, pp.26286~ (2016)

관련 논문AI추천